Screener / SEC EDGAR /CIK 0001759655 /10-K filed Feb 27, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Health Services

Privia Health Group, Inc. PRVA

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 30 Form 144 notices for $71.6M

10-Q, 10-K and Form 144

What PRVA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 31, 2023 to Aug 4, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
David Mountcastle
Chief Financial Officer
Adopted 10b5-1 plan Aug 14, 2026 10-Q Nov 5, 2026
What the company wrote
On August 14, 2026, David Mountcastle, the Company’s Chief Financial Officer, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mountcastle Plan”). The first possible trade date under the New Mountcastle Plan is November 13, 2026, and the end date of the New Mountcastle Plan is November 30, 2027, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mountcastle Plan is 181,230 shares of common stock.
Parth Mehrotra
Chief Executive Officer and a member of the Board
Adopted 10b5-1 plan Aug 7, 2026 10-Q Nov 5, 2026
What the company wrote
On August 7, 2026, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Board, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mehrotra Plan”). The first possible trade date under the New Mehrotra Plan is November 9, 2026, and the end date of the New Mehrotra Plan is August 4, 2028, for a duration of approximately 21 months. The aggregate amount of securities that may be sold under the New Mehrotra Plan is 1,229,423 shares of common stock.
Parth Mehrotra
Chief Executive Officer and a member of the Board
Ended 10b5-1 plan May 13, 2026 10-Q Aug 6, 2026
What the company wrote
On May 13, 2026, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Board, terminated a trading plan for the sale of securities intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act, which he adopted on May 27, 2025 and was scheduled to end on December 31, 2026, with a duration of approximately sixteen months (“the Terminated Mehrotra Plan”). The aggregate amount of securities that could have been sold under the Terminated Mehrotra Plan was 685,270.
Shawn Morris
Adopted 10b5-1 plan Aug 22, 2025 10-Q Nov 6, 2025
What the company wrote
On August 22, 2025, Shawn Morris, a member of the Board, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Morris Plan”). The first possible trade date under the New Morris Plan is December 8, 2025, and the end date of the New Morris Plan is August 31, 2026, for a duration of approximately eight months. The aggregate amount of securities that may be sold under the New Morris Plan is 1,875,000.
David Mountcastle
Chief Financial Officer
Adopted 10b5-1 plan Aug 13, 2025 10-Q Nov 6, 2025
What the company wrote
On August 13, 2025, David Mountcastle, the Company’s Chief Financial Officer, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of Exchange Act (the “New Mountcastle Plan”). The first possible trade date under the New Mountcastle Plan is December 1, 2025, and the end date of the New Mountcastle Plan is November 30, 2026, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mountcastle Plan is 139,005.
Parth Mehrotra
Chief Executive Officer
Adopted 10b5-1 plan May 27, 2025 10-Q Aug 7, 2025
What the company wrote
On May 27, 2025, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Board, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mehrotra Plan”). The first possible trade date under the New Mehrotra Plan is August 25, 2025, and the end date of the New Mehrotra Plan is December 31, 2026, for a duration of approximately sixteen months. The aggregate amount of securities that may be sold under the New Mehrotra Plan is 685,270.
Mr. Morris
Board of Directors
Ended 10b5-1 plan Dec 2, 2024 10-K Feb 27, 2025
What the company wrote
On December 2, 2024, Mr. Morris adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Morris Plan”). The first possible trade date under the New Morris Plan is March 5, 2025, and the end date of the New Morris Plan is November 28, 2025, for a duration of approximately nine months. The aggregate amount of securities that may be sold under the New Morris Plan is 1,875,000.
Parth Mehrotra
Chief Executive Officer and a member of the Company’s Board of Directors
Adopted 10b5-1 plan Nov 8, 2024 10-K Feb 27, 2025
What the company wrote
On November 8, 2024, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mehrotra Plan”). The first possible trade date under the New Mehrotra Plan is March 10, 2025, and the end date of the New Mehrotra Plan is December 31, 2025, for a duration of approximately nine months. The aggregate amount of securities that may be sold under the New Mehrotra Plan is 82,128.
David Mountcastle
Chief Financial Officer
Adopted 10b5-1 plan Aug 30, 2024 10-Q Nov 7, 2024
What the company wrote
On August 30, 2024, David Mountcastle, the Company’s Chief Financial Officer, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of Exchange Act (the "New Mountcastle Plan"). The first possible trade date under the New Mountcastle Plan is December 2, 2024, and the end date of the New Mountcastle Plan is November 25, 2025, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mountcastle Plan is 162,526.
Shawn Morris
Adopted 10b5-1 plan Jun 3, 2024 10-Q Aug 8, 2024
What the company wrote
On June 3, 2024, Shawn Morris, a member of the Board, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the "New Morris Plan"). The first possible trade date under the New Morris Plan is September 3, 2024, and the end date of the New Morris Plan is May 15, 2025, for a duration of approximately eight months. The aggregate amount of securities that may be sold under the New Morris Plan is 2,500,000.
Parth Mehrotra
Chief Executive Officer
Ended 10b5-1 plan May 15, 2024 10-Q Aug 8, 2024
What the company wrote
On May 15, 2024, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Board, terminated a trading plan for the sale of securities intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act, which he adopted on August 16, 2023 and was scheduled to end on November 15, 2024, with a duration of approximately one year (“the Terminated Mehrotra Plan”). The aggregate amount of securities that could have been sold under the Terminated Mehrotra Plan was 456,972. On June 11, 2024, Mr. Mehrotra adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of the Exchange Act (the “New Mehrotra Plan”). The first possible trade date under the New Mehrotra Plan is September 10, 2024, and the end date of the New Mehrotra Plan is May 16, 2025, for a duration of approximately eight months. The New Mehrotra Plan provides for the exercise of 252,477 stock options granted in 2018, 2019 and 2020 and the sale of the number of shares that are necessary to cover all exercise costs, fees and tax withholding obligations incurred in connection with the exercise of such options. The balance of the shares acquired upon the exercise of such options will be held directly by Mr. Mehrotra.
Brighton Family, LLC
Adopted 10b5-1 plan Aug 31, 2023 10-Q Nov 3, 2023
What the company wrote
On August 31, 2023, Brighton Family, LLC adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of Exchange Act (the "New Brighton Plan"). William Sullivan, a member of the Company’s Board of Directors, is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. Mr. Sullivan disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The first possible trade date under the New Brighton Plan is November 30, 2023, and the end date of the New Brighton Plan is November 27, 2024, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Brighton Plan is 3,770,000.
David Mountcastle
Chief Financial Officer
Adopted 10b5-1 plan Aug 31, 2023 10-Q Nov 3, 2023
What the company wrote
On August 31, 2023, David Mountcastle, the Company’s Chief Financial Officer, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of Exchange Act (the "New Mountcastle Plan"). The first possible trade date under the New Mountcastle Plan is November 29, 2023, and the end date of the New Mountcastle Plan is November 29, 2024, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mountcastle Plan is 205,929.
Parth Mehrotra
Chief Executive Officer
Adopted 10b5-1 plan Aug 16, 2023 10-Q Nov 3, 2023
What the company wrote
On August 16, 2023, Parth Mehrotra, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1 of Exchange Act (the "New Mehrotra Plan"). The first possible trade date under the New Mehrotra Plan is November 15, 2023, and the end date of the New Mehrotra Plan is November 15, 2024, for a duration of approximately one year. The aggregate amount of securities that may be sold under the New Mehrotra Plan is 456,972.
Shawn Morris
Chief Executive Officer
Adopted plan Jun 2, 2023 10-Q Aug 3, 2023
Show the other 7 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Jul 9, 2026 Mountcastle David
Officer
21,275 $589K
Jul 7, 2026 Mountcastle David
Officer
600 $17K
Jul 2, 2026 Mountcastle David
Officer
24,734 $680K
Jun 26, 2026 Mountcastle David
Officer
17,196 $433K
May 12, 2026 Mehrotra Parth
Officer, Director
15,647 $354K
May 11, 2026 Mehrotra Parth
Officer, Director
91,403 $2.1M
May 11, 2026 Mountcastle David
Officer
3,385 $77K
May 11, 2026 Mehrotra Parth
Officer, Director
14,036 $317K
May 4, 2026 Mountcastle David
Officer
1,206 $30K
May 1, 2026 Mountcastle David
Officer
7,179 $180K
May 1, 2026 Matthew Shawn Morris
Director
1,628,683 $40.5M
Apr 2, 2026 Mountcastle David
Officer
5,566 $116K
Mar 16, 2026 Mehrotra Parth
Officer, Director
26,509 $586K
Mar 16, 2026 Mountcastle David
Officer
6,391 $141K
Mar 13, 2026 Mehrotra Parth
Officer, Director
27,229 $586K
Mar 13, 2026 Mountcastle David
Officer
6,565 $141K
Mar 12, 2026 Mehrotra Parth
Officer, Director
26,763 $586K
Mar 12, 2026 Mountcastle David
Officer
6,453 $141K
Mar 10, 2026 Mehrotra Parth
Officer, Director
21,097 $479K
Mar 9, 2026 Mehrotra Parth
Officer, Director
23,134 $530K
Mar 9, 2026 Mehrotra Parth
Officer, Director
18,865 $431K
Mar 9, 2026 Fargis Edward C
Officer
4,949 $113K
Mar 9, 2026 Mountcastle David
Officer
5,829 $133K
Mar 6, 2026 Fargis Edward C
Officer
4,394 $102K
Mar 6, 2026 Mehrotra Parth
Officer, Director
21,440 $496K
Mar 6, 2026 Mountcastle David
Officer
5,177 $120K
Feb 27, 2026 Mountcastle David
Officer
7,697 $193K
Feb 26, 2026 Mountcastle David
Officer
5,361 $134K
Dec 12, 2025 Mountcastle David
Officer
23,887 $598K
Dec 12, 2025 Matthew Shawn Morris
Director
833,340 $20.8M
Show the other 22 notices

From the Form 144 XML filed with the SEC, since Dec 12, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRVA/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.